1. Manach C, Williamson G, Morand C, Scalbert A, Remesy C: Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005 Jan;81(1 Suppl):230S-242S. doi: 10.1093/ajcn/81.1.230S. [PubMed:15640486 ]
  2. Ahn-Jarvis JH, Clinton SK, Grainger EM, Riedl KM, Schwartz SJ, Lee ML, Cruz-Cano R, Young GS, Lesinski GB, Vodovotz Y: Isoflavone pharmacokinetics and metabolism after consumption of a standardized soy and soy-almond bread in men with asymptomatic prostate cancer. Cancer Prev Res (Phila). 2015 Nov;8(11):1045-54. doi: 10.1158/1940-6207.CAPR-14-0465. Epub 2015 Aug 14. [PubMed:26276749 ]
  3. Kim Y, Jeon JY, Kim EY, Lim CH, Jang HB, Kim MG: Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects. Clin Pharmacol Drug Dev. 2017 Sep;6(5):499-507. doi: 10.1002/cpdd.343. Epub 2017 Mar 16. [PubMed:28301092 ]
  4. Rufer CE, Bub A, Moseneder J, Winterhalter P, Sturtz M, Kulling SE: Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study. Am J Clin Nutr. 2008 May;87(5):1314-23. doi: 10.1093/ajcn/87.5.1314. [PubMed:18469255 ]